Annual Current Liabilities
$313.90 K
-$81.90 K-20.69%
December 31, 2023
Summary
- As of February 26, 2025, LIXT annual total current liabilities is $313.90 thousand, with the most recent change of -$81.90 thousand (-20.69%) on December 31, 2023.
- During the last 3 years, LIXT annual current liabilities has risen by +$97.40 thousand (+44.99%).
- LIXT annual current liabilities is now -20.69% below its all-time high of $395.80 thousand, reached on December 31, 2022.
Performance
LIXT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$329.00 K
-$92.50 K-21.95%
September 30, 2024
Summary
- As of February 26, 2025, LIXT quarterly total current liabilities is $329.00 thousand, with the most recent change of -$92.50 thousand (-21.95%) on September 30, 2024.
- Over the past year, LIXT quarterly current liabilities has stayed the same.
- LIXT quarterly current liabilities is now -48.96% below its all-time high of $644.60 thousand, reached on March 31, 2022.
Performance
LIXT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
LIXT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.7% | 0.0% |
| 3 y3 years | +45.0% | -18.3% |
| 5 y5 years | +48.8% | -18.3% |
LIXT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.7% | +3.6% | -49.0% | +31.6% |
| 5 y | 5-year | -20.7% | +45.0% | -49.0% | +53.7% |
| alltime | all time | -20.7% | +1423.8% | -49.0% | +2450.4% |
Lixte Biotechnology Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $329.00 K(-21.9%) |
| Jun 2024 | - | $421.50 K(-8.9%) |
| Mar 2024 | - | $462.80 K(+47.4%) |
| Dec 2023 | $313.90 K(-20.7%) | $313.90 K(+0.7%) |
| Sep 2023 | - | $311.70 K(-22.6%) |
| Jun 2023 | - | $402.60 K(+61.0%) |
| Mar 2023 | - | $250.00 K(-36.8%) |
| Dec 2022 | $395.80 K(+30.7%) | $395.80 K(-3.1%) |
| Sep 2022 | - | $408.30 K(-23.2%) |
| Jun 2022 | - | $531.50 K(-17.5%) |
| Mar 2022 | - | $644.60 K(+112.8%) |
| Dec 2021 | $302.90 K(+39.9%) | $302.90 K(+17.1%) |
| Sep 2021 | - | $258.70 K(-31.3%) |
| Jun 2021 | - | $376.30 K(+55.2%) |
| Mar 2021 | - | $242.40 K(+12.0%) |
| Dec 2020 | $216.50 K(-9.0%) | $216.50 K(-2.3%) |
| Sep 2020 | - | $221.50 K(+3.5%) |
| Jun 2020 | - | $214.00 K(-5.0%) |
| Mar 2020 | - | $225.30 K(-5.3%) |
| Dec 2019 | $237.90 K(+12.8%) | $237.90 K(-23.1%) |
| Sep 2019 | - | $309.30 K(+38.7%) |
| Jun 2019 | - | $223.00 K(-8.9%) |
| Mar 2019 | - | $244.80 K(+16.1%) |
| Dec 2018 | $210.90 K(-43.5%) | $210.90 K(-54.1%) |
| Sep 2018 | - | $459.00 K(+35.7%) |
| Jun 2018 | - | $338.30 K(+41.7%) |
| Mar 2018 | - | $238.70 K(-36.0%) |
| Dec 2017 | $373.00 K(+70.6%) | $373.00 K(+45.6%) |
| Sep 2017 | - | $256.20 K(+6.0%) |
| Jun 2017 | - | $241.80 K(-5.0%) |
| Mar 2017 | - | $254.50 K(+16.4%) |
| Dec 2016 | $218.70 K(-23.4%) | $218.70 K(+11.8%) |
| Sep 2016 | - | $195.60 K(+40.1%) |
| Jun 2016 | - | $139.60 K(-27.5%) |
| Mar 2016 | - | $192.60 K(-32.6%) |
| Dec 2015 | $285.60 K | $285.60 K(+28.5%) |
| Sep 2015 | - | $222.20 K(+12.1%) |
| Jun 2015 | - | $198.20 K(-22.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $254.20 K(-7.0%) |
| Dec 2014 | $273.40 K(-15.0%) | $273.40 K(-32.0%) |
| Sep 2014 | - | $402.30 K(+23.0%) |
| Jun 2014 | - | $327.20 K(+15.1%) |
| Mar 2014 | - | $284.20 K(-11.7%) |
| Dec 2013 | $321.80 K(+23.2%) | $321.80 K(+9.6%) |
| Sep 2013 | - | $293.50 K(+10.3%) |
| Jun 2013 | - | $266.00 K(-1.5%) |
| Mar 2013 | - | $270.10 K(+3.4%) |
| Dec 2012 | $261.20 K(-25.5%) | $261.20 K(+6.0%) |
| Sep 2012 | - | $246.50 K(-29.8%) |
| Jun 2012 | - | $351.30 K(-24.8%) |
| Mar 2012 | - | $467.10 K(+33.2%) |
| Dec 2011 | $350.70 K(+79.8%) | $350.70 K(-3.2%) |
| Sep 2011 | - | $362.40 K(+7.5%) |
| Jun 2011 | - | $337.10 K(+11.4%) |
| Mar 2011 | - | $302.50 K(+55.0%) |
| Dec 2010 | $195.10 K(-35.0%) | $195.10 K(-18.6%) |
| Sep 2010 | - | $239.80 K(-25.7%) |
| Jun 2010 | - | $322.80 K(-1.3%) |
| Mar 2010 | - | $327.00 K(+8.9%) |
| Dec 2009 | $300.30 K(-20.0%) | $300.30 K(-29.8%) |
| Sep 2009 | - | $427.50 K(+60.9%) |
| Jun 2009 | - | $265.70 K(+2.7%) |
| Mar 2009 | - | $258.60 K(-31.1%) |
| Dec 2008 | $375.20 K(+48.8%) | $375.20 K(+40.2%) |
| Sep 2008 | - | $267.70 K(+24.6%) |
| Jun 2008 | - | $214.90 K(-9.2%) |
| Mar 2008 | - | $236.70 K(-6.1%) |
| Dec 2007 | $252.20 K(+102.6%) | $252.20 K(+3.8%) |
| Sep 2007 | - | $243.00 K(+19.0%) |
| Jun 2007 | - | $204.20 K(-54.5%) |
| Mar 2007 | - | $449.00 K(+260.6%) |
| Dec 2006 | $124.50 K(+504.4%) | $124.50 K(+13.3%) |
| Sep 2006 | - | $109.90 K(-78.9%) |
| Jun 2006 | - | $520.30 K(+3933.3%) |
| Mar 2006 | - | $12.90 K |
| Dec 2005 | $20.60 K | - |
FAQ
- What is Lixte Biotechnology Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual current liabilities year-on-year change?
- What is Lixte Biotechnology Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly current liabilities year-on-year change?
What is Lixte Biotechnology Holdings annual total current liabilities?
The current annual current liabilities of LIXT is $313.90 K
What is the all time high annual current liabilities for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual total current liabilities is $395.80 K
What is Lixte Biotechnology Holdings annual current liabilities year-on-year change?
Over the past year, LIXT annual total current liabilities has changed by -$81.90 K (-20.69%)
What is Lixte Biotechnology Holdings quarterly total current liabilities?
The current quarterly current liabilities of LIXT is $329.00 K
What is the all time high quarterly current liabilities for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly total current liabilities is $644.60 K
What is Lixte Biotechnology Holdings quarterly current liabilities year-on-year change?
Over the past year, LIXT quarterly total current liabilities has changed by $0.00 (0.00%)